Masayo Shamoto‐Nagai

Mitochondrial Genome Variation in Eastern Asia and the Peopling of Japan

Masashi Tanaka, Vicente M. Cabrera, Ana González et al. · Genome Research · 2004 · 524 citations · Full text

Mitochondrial permeability transition mediates apoptosis induced by <i>N</i>‐methyl(<i>R</i>)salsolinol, an endogenous neurotoxin, and is inhibited by Bcl‐2 and rasagiline, <i>N</i>‐propargyl‐1(<i>R</i>)‐aminoindan

Yukihiro Akao, Wakako Maruyama, Shigeomi Shimizu et al. · Journal of Neurochemistry · 2002 · 164 citations

An inhibitor of mitochondrial complex I, rotenone, inactivates proteasome by oxidative modification and induces aggregation of oxidized proteins in SH‐SY5Y cells

Masayo Shamoto‐Nagai, Wakako Maruyama, Yoji Kato et al. · Journal of Neuroscience Research · 2003 · 141 citations

An anti-Parkinson's disease drug, N-propargyl-1(R)-aminoindan (rasagiline), enhances expression of anti-apoptotic Bcl-2 in human dopaminergic SH-SY5Y cells

Yukihiro Akao, Wakako Maruyama, Hong Yi et al. · Neuroscience Letters · 2002 · 123 citations

Medicinal Chemistry, Functional Selectivity, Medicine +12

In parkinsonian substantia nigra, α-synuclein is modified by acrolein, a lipid-peroxidation product, and accumulates in the dopamine neurons with inhibition of proteasome activity

Masayo Shamoto‐Nagai, W. Maruyama, Yoshio Hashizume et al. · Journal of Neural Transmission · 2007 · 113 citations

Neurodegenerative Diseases, Biochemistry, Medicine +12